Recent Articles from MarketBeat
MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Website: https://www.marketbeat.com
Mesoblast Eyes Heart Failure Filing as Back Pain Trial and RYONCIL Expansion Advancemarketbeat.com
Mesoblast (NASDAQ:MESO) is preparing a regulatory filing for its cell therapy rexlemestrocel-L in a rare population of patients with end-stage heart failure, while awaiting pivotal trial results in chronic low back pain and advancing an adult study of its approved product RYONCIL.
Chief Executive O
Via MarketBeat · November 21, 2026
Deutsche Bank Sees 2026 Revenue Above €33 Billion, Reaffirms Cost Targetmarketbeat.com
Deutsche Bank (NYSE:DB) expects 2026 revenue to exceed €33 billion and remains committed to its €21.3 billion cost guidance, CEO Christian Sewing said, citing growth across the bank’s businesses and stronger-than-expected cost performance.
Speaking with JPMorgan analyst Kian Abouhossein, Sewing sai
Via MarketBeat · November 21, 2026
ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbomarketbeat.com
Via MarketBeat · November 21, 2026
SAP CFO Sees Headcount Declining as AI Boosts Productivity, Plans New Revenue Metricmarketbeat.com
SAP (NYSE:SAP) expects its headcount to decline over time as artificial intelligence improves productivity, while it plans to introduce a new revenue measure in January to show investors how its AI-related businesses are growing, Chief Financial Officer Dominik Asam said.
Speaking at a Morgan Stanl
Via MarketBeat · November 21, 2026
Owens Corning's Stock Slump May Have a Silver Lining for Dividend Investorsmarketbeat.com
Via MarketBeat · November 21, 2026
Cognex Sees More Margin Upside, Targets Deeper Customer Ties in 2027marketbeat.com
Cognex (NASDAQ:CGNX) sees room to expand margins further and plans to shift its sales focus toward deepening relationships with recently acquired customers, Chief Financial Officer Dennis Fehr said at a Stephens conference in Nashville.
Fehr also outlined the rationale for the company’s announced R
Via MarketBeat · November 21, 2026
The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocksmarketbeat.com
Via MarketBeat · November 21, 2026
Endeavour Silver Maps $585 Million Pitarrilla Mine, With Production Possible by 2030marketbeat.com
Endeavour Silver (NYSE:EXK) outlined an 18-year underground mine at its Pitarrilla project in Durango, Mexico, with estimated initial construction costs of $585 million and potential production starting in 2030, subject to permitting and a construction decision.
The feasibility study projects avera
Via MarketBeat · November 21, 2026
Anthropic's Record IPO Could Ease a Major Concern for Broadcom Investorsmarketbeat.com
Via MarketBeat · November 21, 2026
Jazz Pharmaceuticals CEO Touts Ziihera Launch, Pipeline After Raising Revenue Guidancemarketbeat.com
Jazz Pharmaceuticals (NASDAQ:JAZZ) is counting on new drug launches, pipeline studies and acquisitions to sustain growth across its sleep, epilepsy and oncology businesses, President and CEO Renee Gala said at an investor event.
Gala pointed to third-quarter revenue of $1.24 billion, up 10% from a
Via MarketBeat · November 21, 2026
Zillow Group Sees Ad Shift Headwind Easing as Rentals and Mortgages Fuel Growthmarketbeat.com
Zillow Group (NASDAQ:Z) expects the revenue headwind from its shift away from prepaid advertising to begin easing after the company completes the transition in the first half of next year, Chief Operating Officer Jeremy Hofmann said at the RBC TIMT Conference.
The company is moving its real estate
Via MarketBeat · November 21, 2026
Builders FirstSource Targets 18% Earnings Growth Despite Modest Housing Outlookmarketbeat.com
Builders FirstSource (NYSE:BLDR) outlined five-year targets for sales and earnings growth at its 2026 Investor Day, betting that market share gains, acquisitions and productivity improvements can lift results even with only a modest housing recovery.
The building materials supplier is targeting 8%
Via MarketBeat · November 21, 2026
NeoGenomics Touts 29% Sequencing Growth, Plans Sales Push for Cancer Testsmarketbeat.com
NeoGenomics (NASDAQ:NEO) executives highlighted growth in next-generation sequencing tests and expanding use of its cancer diagnostics portfolio, while outlining plans to invest further in sales and minimal residual disease testing in 2027.
Speaking at the Stephens Conference, CEO Tony Zook said th
Via MarketBeat · November 21, 2026
Akamai Technologies Turns Away AI Business as Power Shortage Meets $14 Billion Deal Surgemarketbeat.com
Akamai Technologies (NASDAQ:AKAM) is turning away some potential AI infrastructure business because of limited power availability, even as it has signed $14 billion in large deals this year, Chief Financial Officer Ed McGowan said at an event hosted by RBC software analyst Rishi Jaluria.
McGowan sa
Via MarketBeat · November 21, 2026
Zebra Technologies Sees 2027 Growth as Delivery Refreshes Offset Memory Cost Pressuresmarketbeat.com
Zebra Technologies (NASDAQ:ZBRA) expects strong demand and large delivery-device refreshes to support sales growth in 2027, while higher memory costs are prompting the company to raise prices and build inventory, Chief Financial Officer Nathan Winters said at a Stephens investor conference in Nashvi
Via MarketBeat · November 21, 2026
DoorDash CEO Says AI Spending Jumped 20-Fold, With More Growth Aheadmarketbeat.com
DoorDash (NASDAQ:DASH) CEO Tony Xu said the company’s artificial intelligence spending rose 20-fold this year before leveling off, but he expects it to grow again as the delivery platform develops more sophisticated tools for customers.
Speaking at an investor conference, Xu also discussed DoorDash
Via MarketBeat · November 21, 2026
Recursion Pharmaceuticals Reaches FDA Agreement on Key Endpoint for Phase III FAP Trialmarketbeat.com
Recursion Pharmaceuticals (NASDAQ:RXRX) has aligned with the U.S. Food and Drug Administration on the primary endpoint for a planned Phase III study of its experimental treatment for familial adenomatous polyposis, or FAP, CEO Najat Khan said at the Jefferies Healthcare Conference in London.
The co
Via MarketBeat · November 21, 2026
Incyte Bets on Drug Pipeline and Deals for Growth After Jakafi Exclusivity Endsmarketbeat.com
Incyte (NASDAQ:INCY) is counting on a pipeline of cancer and immunology treatments, along with potential acquisitions, to support growth after JAKAFI loses exclusivity, executives said at the Jefferies Global Healthcare Conference in London.
President and CEO Bill Meury said the company’s core busi
Via MarketBeat · November 20, 2026
Incyte Maps Post-JAKAFI Growth as Key Drug Data and 2027 Launch Loommarketbeat.com
Incyte (NASDAQ:INCY) is counting on growth from its existing medicines and a pipeline of late-stage treatments to support the company after JAKAFI loses exclusivity at the end of 2028, executives said at the UBS Global Biopharma Conference in London.
President and Global Head of Research and Develo
Via MarketBeat · November 20, 2026
Synchrony Financial Puts Lending Discipline First, Sees Walmart as Growth Opportunitymarketbeat.com
Synchrony Financial (NYSE:SYF) is prioritizing lending discipline over faster loan growth as it navigates consumer affordability pressures, Chief Financial Officer Brian Wenzel said at TD’s Financials & Fintech Conference.
Wenzel said the company aims to maintain a loss rate of 5.5% to 6% and d
Via MarketBeat · November 20, 2026
Campbell's Plans $500 Million in Savings as Sales and Profit Slidemarketbeat.com
Campbell's (NASDAQ:CPB) shareholders elected all 12 director nominees and approved the company’s executive compensation and long-term incentive plan proposals at its 2026 annual meeting, according to preliminary voting results. A shareholder proposal seeking more reporting on the company’s regenerat
Via MarketBeat · November 20, 2026
Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]marketbeat.com
According to a recent New York Times article, Americans have been absorbing years of rising beef prices but have not yet cut back on it. However, our research reveals that the average American household does indeed have a breaking point, and when it comes to a large pack of ribeye, that breaking point is 16% away from current prices.
Via MarketBeat · November 20, 2026
Intercontinental Exchange Eyes Growth in Energy, Retail Trading and Mortgage AImarketbeat.com
Intercontinental Exchange (NYSE:ICE) sees opportunities to expand its trading, data and mortgage technology businesses by applying its existing infrastructure to adjacent markets, Chief Financial Officer Warren Gardiner said at a conference.
Gardiner said the company looks for markets with ineffici
Via MarketBeat · November 20, 2026
Lexicon Pharmaceuticals Sets Sights on Heart Trial Results, Diabetes Drug Resubmission in 2027marketbeat.com
Lexicon Pharmaceuticals (NASDAQ:LXRX) expects first-quarter results next year from a late-stage study of sotagliflozin in hypertrophic cardiomyopathy, while preparing to resubmit the drug for type 1 diabetes in the first quarter of 2027, company executives said at a Jefferies healthcare conference.
Via MarketBeat · November 20, 2026
Alnylam Pharmaceuticals Expands Sales Force to Accelerate AMVUTTRA Demandmarketbeat.com
Alnylam Pharmaceuticals (NASDAQ:ALNY) is expanding its sales force and working to reach more physicians as it seeks to accelerate demand for AMVUTTRA in transthyretin amyloid cardiomyopathy, or ATTR-CM, executives said at the Jefferies Global Healthcare Conference in London.
CEO Yvonne Greenstreet
Via MarketBeat · November 20, 2026
Rockwell Automation Raises Margin Target, Bets on Robots and AI at Investor Daymarketbeat.com
Rockwell Automation (NYSE:ROK) raised its long-term margin targets and announced an agreement to acquire European autonomous mobile robot maker AGILOX at its annual investor day, as executives outlined plans to expand the company’s industrial artificial intelligence offerings.
Chairman and CEO Blak
Via MarketBeat · November 20, 2026
Sandisk’s Data Center Portfolio Soars 1,700% as AI Demand Reshapes NAND Businessmarketbeat.com
Sandisk (NASDAQ:SNDK) is shifting more of its NAND flash business toward data centers after a sharp rise in demand, while using long-term customer contracts to secure orders and manage the economics of its production, executives said at a Morgan Stanley event.
Chairman and CEO Dave Goeckeler said t
Via MarketBeat · November 20, 2026
Moog Q4 Earnings Call Highlightsmarketbeat.com
Moog (NYSE:MOG.A) reported record fiscal 2026 sales and higher earnings, and forecast further revenue growth in 2027 as demand for defense equipment, commercial aircraft components and data center cooling pumps supports its business.
The company’s fiscal 2026 sales rose 17% to $4.5 billion, while a
Via MarketBeat · November 20, 2026
If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel Itmarketbeat.com
Via MarketBeat · November 20, 2026
MINISO Group Q3 Earnings Call Highlightsmarketbeat.com
MINISO Group (NYSE:MNSO) reported a 14.3% increase in third-quarter revenue, as strong sales in China offset slower overseas growth and a decline at its TOP TOY business.
Revenue reached CNY 6.63 billion in the third quarter of 2026, while adjusted operating profit excluding foreign-exchange gains
Via MarketBeat · November 20, 2026
What Ellington Credit (EARN) Said on Its Q2 Earnings Callmarketbeat.com
Ellington Credit NYSE: EARN reported higher net investment income in the third quarter of 2026, while announcing a lower monthly distribution that management said would leave more capital available for reinvestment.
Via MarketBeat · November 20, 2026
Frontline Q3 Earnings Call Highlightsmarketbeat.com
Frontline (NYSE:FRO) expects a record-breaking fourth quarter as tanker rates remain historically high despite a recent correction, CEO Lars Barstad said on the company’s third-quarter earnings call. He cautioned that the strong market has come with operational strain and growing concerns about the
Via MarketBeat · November 20, 2026
3 Dividend ETFs Offering Steadier Footing in a Shaky Marketmarketbeat.com
Via MarketBeat · November 20, 2026
WeRide Q3 Earnings Call Highlightsmarketbeat.com
WeRide (NASDAQ:WRD) reported an 88% increase in third-quarter revenue and a narrower sequential net loss as overseas Robotaxi operations expanded, while management said it expects to reach positive quarterly free cash flow in 2028.
Revenue rose to a record CNY 321.5 million in the third quarter of
Via MarketBeat · November 20, 2026
BJ's Wholesale Club Q3 Earnings Call Highlightsmarketbeat.com
BJ's Wholesale Club (NYSE:BJ) raised its full-year sales and earnings outlook after reporting third-quarter results ahead of its expectations, as a settlement-funded anniversary promotion drove more visits and purchases.
Net sales rose 17.7% from a year earlier to $6.1 billion, while comparable clu
Via MarketBeat · November 20, 2026
What Post (POST) Said on Its Q4 Earnings Callmarketbeat.com
Post (NYSE:POST) expects pricing, productivity initiatives and foodservice growth to help offset inflation as fiscal 2027 progresses, after fourth-quarter adjusted EBITDA came in modestly above management’s expectations despite higher freight and diesel costs.
President and CEO Nico Catoggio said v
Via MarketBeat · November 20, 2026
Definium Therapeutics Eyes 2027 FDA Filing for LSD-Based Drug, Weighs Two Treatment Pathsmarketbeat.com
Definium Therapeutics (NASDAQ:DFTX) expects to file a new drug application for its lead LSD-based treatment in the first half of 2027, though the company has not settled on whether to seek approval for generalized anxiety disorder, major depressive disorder or both at the outset.
CEO Rob Barrow sai
Via MarketBeat · November 20, 2026
Buckle Q3 Earnings Call Highlightsmarketbeat.com
Buckle (NYSE:BKE) reported higher third-quarter sales but a slight decline in profit as store-related costs and increased spending on marketing and labor weighed on margins.
Net income for the 13 weeks ended Oct. 31, 2026, fell to $48 million, or $0.94 per diluted share, from $48.7 million, or $0.9
Via MarketBeat · November 20, 2026
What Bending Spoons (BSP) Said on Its Q3 Earnings Callmarketbeat.com
Bending Spoons (NASDAQ:BSP) reported third-quarter revenue of $780 million, up 125% from a year earlier, and raised its full-year outlook as newly acquired businesses contributed to results. Organic revenue growth was 3%, held back in part by declines at Remini and disruption from AOL’s advertising
Via MarketBeat · November 20, 2026
Matthews International Q4 Earnings Call Highlightsmarketbeat.com
Matthews International (NASDAQ:MATW) finished fiscal 2026 near the high end of its adjusted earnings target, but its new chief executive said the company must improve cash generation, reduce debt and simplify operations after a year of divestitures and weak demand in parts of its industrial business
Via MarketBeat · November 20, 2026
Cracks in the Crockery? Williams-Sonoma Insiders Sell Sharesinsidertrades.com
Williams-Sonoma insider selling reflects 10b5-1 plans and compensation, not weakness, as Q3 margins widened and capital returns continued despite a post-earnings pullback.
Via MarketBeat · November 20, 2026
Lazard’s New ETF Targets Monthly Income With Junk Bondsmarketbeat.com
Via MarketBeat · November 20, 2026
Apple's Rare Samsung Memory Plan Could Solve One Problem and Create Anothermarketbeat.com
Via MarketBeat · November 20, 2026
BitFuFu Q3 Earnings Call Highlightsmarketbeat.com
BitFuFu (NASDAQ:FUFU) reported third-quarter 2026 net income of $24.9 million, reversing a loss in the prior quarter as a recovery in Bitcoin prices generated a sizable fair value gain on its holdings and related items.
The Bitcoin mining and services company said revenue fell to $37.7 million from
Via MarketBeat · November 20, 2026
Ecolab Raises Long-Term Targets as AI Infrastructure Opens a $60 Billion Opportunitymarketbeat.com
Ecolab (NYSE:ECL) set higher long-term growth and profitability targets at its 2026 Investor Day, saying investments in technology, life sciences and AI infrastructure are expanding its market opportunities.
The company is targeting organic sales growth of 6% to 8% for 2027 and beyond, up from its
Via MarketBeat · November 20, 2026
Palo Alto Networks' Q1 Beat Gives Its Stock Rally Another Reason to Runmarketbeat.com
Via MarketBeat · November 20, 2026
Airfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter Testmarketbeat.com
Via MarketBeat · November 20, 2026
Sanofi Maps Vaccine Pipeline With Flu-COVID and Pneumococcal Trial Results Aheadmarketbeat.com
Sanofi (NASDAQ:SNY) is advancing a slate of vaccine candidates targeting respiratory infections, pneumococcal disease and acne, with several clinical readouts expected over the next 18 months, according to its head of vaccines research and development.
Jean-François Toussaint said the company recen
Via MarketBeat · November 20, 2026
What RLX Technology (RLX) Said on Its Q3 Earnings Callmarketbeat.com
RLX Technology (NYSE:RLX) reported its highest quarterly revenue since the second quarter of 2022, as the July consolidation of a Western European distribution business helped drive a sharp increase in international sales.
Third-quarter 2026 net revenue reached CNY 1.92 billion, up 69.7% from a yea
Via MarketBeat · November 20, 2026
Hard Drives Were Left for Dead, But Seagate and Western Digital Are Soaringmarketbeat.com
Via MarketBeat · November 20, 2026
Ionis Pharmaceuticals Pushes TRYNGOLZA Access as Insurer Requirements Slow Launchmarketbeat.com
Ionis Pharmaceuticals (NASDAQ:IONS) is working to accelerate prescriptions for TRYNGOLZA as physicians gain experience with the drug and patients navigate insurance requirements, CEO Brett Monia said at the Jefferies Global Healthcare Conference.
Three months into the drug’s launch for severe hyper
Via MarketBeat · November 20, 2026
Tesla and SpaceX May Form a $3.4 Trillion Giant, But Who Really Benefits?marketbeat.com
Via MarketBeat · November 20, 2026
2 Utility Stocks May Offer Relief From AI Volatility, But Rates Are the Real Storymarketbeat.com
Via MarketBeat · November 20, 2026
Home Depot Posts a Q3 Double Beat, But Is Its Rebound Built to Last?marketbeat.com
Via MarketBeat · November 20, 2026
Tilray Brands Board Overhaul Falls Short Despite 77% Support; CEO Targets $30 Million in Savingsmarketbeat.com
Tilray Brands (NASDAQ:TLRY) shareholders re-elected three directors and ratified the company’s auditor at its annual meeting, but a proposal to declassify the board fell short of the required support despite receiving a majority of votes cast.
Chairman and CEO Irwin Simon also outlined plans to cut
Via MarketBeat · November 20, 2026
Ally Financial Bets on Loan Growth to Boost Returns as Lease Losses Mountmarketbeat.com
Ally Financial (NYSE:ALLY) is counting on growth in higher-margin auto and corporate loans to lift profitability, even as recalled vehicles weigh on its leasing business and deposit competition intensifies, Chief Financial Officer Russ Hutchinson said at a conference.
Hutchinson said Ally’s return
Via MarketBeat · November 20, 2026
V.F. Targets $9.8 Billion in Revenue as Vans Turnaround Takes Shapemarketbeat.com
V.F. (NYSE:VFC) expects revenue of at least $9.8 billion and an operating margin of about 9% next year, executives said at JPMorgan’s Global Luxury & Brands Conference in Paris, as the company pursues growth in its outdoor brands and a turnaround at Vans.
CEO Bracken Darrell said the company al
Via MarketBeat · November 20, 2026
Intellia Therapeutics Preps Gene-Editing Launch as FDA Review Advancesmarketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) is preparing for a potential U.S. launch of its hereditary angioedema gene-editing therapy, lonvo-z, while advancing late-stage studies in transthyretin amyloidosis, company executives said during a Jefferies fireside chat.
The Food and Drug Administration is rev
Via MarketBeat · November 20, 2026
Procter & Gamble Targets Up to $10 Billion in Savings With AI and Automationmarketbeat.com
Procter & Gamble (NYSE:PG) announced a productivity target of up to $10 billion over four fiscal years as it outlined plans to use artificial intelligence, supply chain automation and product innovation to accelerate growth.
At its 2026 Investor Day in Cincinnati, the consumer-products company
Via MarketBeat · November 20, 2026
Magna International Targets 15% EPS Growth as Automation and Buybacks Drive Strategymarketbeat.com
Magna International (NYSE:MGA) expects operational improvements, growth beyond its core automotive markets and share buybacks to help drive earnings growth over the next four years, even as it assumes only modest growth in vehicle production.
At a company presentation hosted by Scotiabank analyst J
Via MarketBeat · November 20, 2026
Arrowhead Pharmaceuticals Eyes $3 Billion REDEMPLO Opportunity as FDA Review Loomsmarketbeat.com
Arrowhead Pharmaceuticals (NASDAQ:ARWR) is preparing for a potential expansion of its recently launched drug REDEMPLO into severe hypertriglyceridemia, while advancing experimental treatments for mixed hyperlipidemia, neurological diseases and obesity-related conditions, CEO Chris Anzalone said at a
Via MarketBeat · November 20, 2026
BioCryst Pharmaceuticals Sees Revenue Near Top of Guidance as It Expands HAE Portfoliomarketbeat.com
BioCryst Pharmaceuticals (NASDAQ:BCRX) expects revenue to land at the upper end of its $625 million to $645 million guidance range this year, CEO Charlie Gayer said at a Jefferies conference, while outlining plans to expand its hereditary angioedema portfolio and add rare-disease assets.
Gayer said
Via MarketBeat · November 20, 2026
Apollo Global Management Targets Over 20% Earnings Growth in 2027 as Credit Expandsmarketbeat.com
Apollo Global Management (NYSE:APO) expects its credit origination business to keep growing and is targeting more than 20% growth in fee-related earnings in 2027, Chief Financial Officer Martin Kelly said at a TD Cowen event.
Kelly described the market environment as constructive for Apollo’s lendi
Via MarketBeat · November 19, 2026
Magna International Targets Above-Market Growth Through 2030, With China and New Industries in Focusmarketbeat.com
Magna International (NYSE:MGA) expects to grow faster than the automotive market through 2030 by adding content to vehicles, expanding its customer base and moving into adjacent industries, Chief Financial Officer Phil Fracassa said at the Global Auto Conference.
The auto supplier has set a target
Via MarketBeat · November 19, 2026
Strategy Buys Back $3 Billion in STRC Shares as Credit Markets Tightenmarketbeat.com
Strategy (NASDAQ:MSTR) is buying back its STRC preferred shares as credit markets tighten, with executives saying the company is prioritizing support for the security over rapid growth in its Bitcoin-backed financing business.
During an investor question-and-answer session, Founder and Executive Ch
Via MarketBeat · November 19, 2026
What Gorilla Technology Group (GRRR) Said on Its Q3 Earnings Callmarketbeat.com
Gorilla Technology Group (NASDAQ:GRRR) reported record third-quarter 2026 revenue of $69.5 million, as growth in its technology and infrastructure business outpaced the early contribution from its artificial intelligence computing operations.
Revenue rose 163% from approximately $26.5 million a yea
Via MarketBeat · November 19, 2026
What GAP (GAP) Said on Its Q3 Earnings Callmarketbeat.com
GAP (NYSE:GAP) lowered its full-year revenue and profit outlook after unusually warm weather and a slower start to November weighed on demand for fall apparel, even as third-quarter earnings exceeded its expectations.
The retailer reported fiscal third-quarter net sales of $4 billion, up 2% from a
Via MarketBeat · November 19, 2026
What Elastic (ESTC) Said on Its Q2 Earnings Callmarketbeat.com
Elastic (NYSE:ESTC) reported 17% revenue growth for its fiscal 2027 second quarter as strong customer consumption and demand for security and search products helped it exceed its guidance.
The company also raised its constant-currency growth outlook for the year, although a stronger U.S. dollar off
Via MarketBeat · November 19, 2026
HSBC CEO Sees Deposit Growth and Asian Wealth as Bank Bets on AImarketbeat.com
HSBC (NYSE:HSBC) Chief Executive Officer Georges Elhedery said the bank has room to compete for deposits in Hong Kong and the U.K. while investing in wealth management, transaction banking and artificial intelligence.
Speaking at a JPMorgan financial conference in London, Elhedery said Hong Kong de
Via MarketBeat · November 19, 2026
Stryker Sticks to Growth Goals Despite Cyberattack and Slower Orthopedic Marketmarketbeat.com
Stryker (NYSE:SYK) expects to maintain its long-term growth and margin goals despite a cyberattack, supply disruptions and a softer U.S. orthopedic market, executives said at the London Healthcare Conference.
President and Chief Operating Officer Spencer Stiles, who is set to become CEO in January,
Via MarketBeat · November 19, 2026
ESCO Technologies Q4 Earnings Call Highlightsmarketbeat.com
ESCO Technologies (NYSE:ESE) reported record fiscal 2026 revenue and adjusted earnings, with orders rising across its businesses and the recently completed Megger acquisition expected to help drive a sharp increase in sales in fiscal 2027.
Revenue for fiscal 2026 rose 21% to just over $1.3 billion,
Via MarketBeat · November 19, 2026
What Globant (GLOB) Said on Its Q3 Earnings Callmarketbeat.com
Globant (NYSE:GLOB) reported a 1% decline in third-quarter revenue as weakness in the Middle East offset growth among its largest customers, while its AI services business more than doubled its annualized revenue run rate from the prior quarter.
Revenue was $611.1 million, matching the midpoint of
Via MarketBeat · November 19, 2026
Keysight Technologies Q4 Earnings Call Highlightsmarketbeat.com
Keysight Technologies (NYSE:KEYS) reported record fiscal fourth-quarter orders and revenue, as demand for testing equipment used in artificial intelligence infrastructure helped drive growth across its businesses. The company expects revenue to grow 20% in fiscal 2027, although demand continues to o
Via MarketBeat · November 19, 2026
What Intuit (INTU) Said on Its Q1 Earnings Callmarketbeat.com
Intuit (NASDAQ:INTU) reported fiscal first-quarter revenue growth of 12% and results above its guidance, but lowered its full-year revenue outlook after Credit Karma fell short of expectations.
The company also said it had agreed to sell Mailchimp to Bending Spoons, with the transaction expected to
Via MarketBeat · November 19, 2026